Human disease-causing NOG missense mutations:: Effects on noggin secretion, dimer formation, and bone morphogenetic protein binding

被引:74
作者
Marcelino, J
Sciortino, CM
Romero, MF
Ulatowski, LM
Ballock, RT
Economides, AN
Eimon, PM
Harland, RM
Warman, ML [1 ]
机构
[1] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA
[4] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
[7] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet & Dev, Berkeley, CA 94720 USA
关键词
D O I
10.1073/pnas.201367598
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
Secreted noggin protein regulates bone morphogenetic protein activity during development. In mice, a complete loss of noggin protein leads to multiple malformations including joint fusion, whereas mice heterozygous for Nog loss-of-function mutations are normal. In humans, heterozygous NOG missense mutations have been found in patients with two autosomal dominant disorders of joint development, multiple synostosis syndrome (SYNS1) and a milder disorder proximal symphalangism (SYM1). This study investigated the effect of one SYNS1 and two SYM1 disease-causing missense mutations on the structure and function of noggin. The SYNS1 mutation abolished, and the SYM1 mutations reduced, the secretion of functional noggin dimers in transiently transfected COS-7 cells. Coexpression of mutant noggin with wild-type noggin, to resemble the heterozygous state, did not interfere with wildtype noggin secretion. These data indicate that the human disease-causing mutations are hypomorphic alleles that reduce secretion of functional dimeric noggin. Therefore, we conclude that noggin has both species-specific and joint-specific dosage-dependent roles during joint formation. Surprisingly, in contrast to the COS-7 cell studies, the SYNS1 mutant was able to form dimers in Xenopus laevis oocytes. This finding indicates that there also exist species-specific differences in the ability to process mutant noggin polypeptides.
引用
收藏
页码:11353 / 11358
页数:6
相关论文
共 26 条
[1]
Wnt signaling in Xenopus embryos inhibits Bmp4 expression and activates neural development [J].
Baker, JC ;
Beddington, RSP ;
Harland, RM .
GENES & DEVELOPMENT, 1999, 13 (23) :3149-3159
[2]
Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton [J].
Brunet, LJ ;
McMahon, JA ;
McMahon, AP ;
Harland, RM .
SCIENCE, 1998, 280 (5368) :1455-1457
[3]
Chang CB, 1999, DEVELOPMENT, V126, P3347
[4]
Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases [J].
Constam, DB ;
Robertson, EJ .
JOURNAL OF CELL BIOLOGY, 1999, 144 (01) :139-149
[5]
Head induction by simultaneous repression of Bmp and Wnt signalling in Xenopus [J].
Glinka, A ;
Wu, W ;
Onichtchouk, D ;
Blumenstock, C ;
Niehrs, C .
NATURE, 1997, 389 (6650) :517-519
[6]
Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis [J].
Gong, YQ ;
Krakow, D ;
Marcelino, J ;
Wilkin, D ;
Chitayat, D ;
Babul-Hirji, R ;
Hudgins, L ;
Cremers, CW ;
Cremers, FPM ;
Brunner, HG ;
Reinker, K ;
Rimoin, DL ;
Cohn, DH ;
Goodman, FR ;
Reardon, W ;
Patton, M ;
Francomano, CA ;
Warman, ML .
NATURE GENETICS, 1999, 21 (03) :302-304
[7]
Bone morphogenetic proteins in human bone regeneration [J].
Groeneveld, EHJ ;
Burger, EH .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 142 (01) :9-21
[8]
Bone morphogenetic proteins in development [J].
Hogan, BLM .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (04) :432-438
[9]
Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development [J].
Kosaki, K ;
Bassi, MT ;
Kosaki, R ;
Lewin, M ;
Belmont, J ;
Schauer, G ;
Casey, B .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (03) :712-721
[10]
Localization of a multiple synostoses syndrome disease gene to chromosome 17q21-22 [J].
Krakow, D ;
Reinker, K ;
Powell, B ;
Cantor, R ;
Priore, MA ;
Garber, A ;
Lachman, RS ;
Rimoin, DL ;
Cohn, DH .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (01) :120-124